Andreas Lind
Andreas Lind
Infectious diseases, Oslo University Hospital
Verified email at medisin.uio.no - Homepage
Title
Cited by
Cited by
Year
How something can be said about telling more than we can know: On choice blindness and introspection
P Johansson, L Hall, S Sikström, B Tärning, A Lind
Consciousness and cognition 15 (4), 673-692, 2006
2902006
How the polls can be both spot on and dead wrong: Using choice blindness to shift political attitudes and voter intentions
L Hall, T Strandberg, P Pärnamets, A Lind, B Tärning, P Johansson
PloS one 8 (4), e60554, 2013
1512013
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, ...
Proceedings of the National Academy of Sciences 117 (40), 25018-25025, 2020
722020
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
FO Pettersen, EA Torheim, AEA Dahm, IS Aaberge, A Lind, M Holm, ...
Journal of virology 85 (13), 6557-6566, 2011
692011
Speakers’ acceptance of real-time speech exchange indicates that we use auditory feedback to specify the meaning of what we say
A Lind, L Hall, B Breidegard, C Balkenius, P Johansson
Psychological Science 25 (6), 1198-1205, 2014
492014
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
T Ueland, JC Holter, AR Holten, KE Müller, A Lind, GK Bekken, ...
The Journal of Infection, 2020
352020
DAVID: An open-source platform for real-time transformation of infra-segmental emotional cues in running speech
L Rachman, M Liuni, P Arias, A Lind, P Johansson, L Hall, D Richardson, ...
Behavior research methods 50 (1), 323-343, 2018
342018
Auditory feedback of one’s own voice is used for high-level semantic monitoring: the “self-comprehension” hypothesis
A Lind, L Hall, B Breidegard, C Balkenius, P Johansson
Frontiers in human neuroscience 8, 166, 2014
242014
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
M Trøseid, A Lind, P Nowak, B Barqasho, B Heger, I Lygren, KK Pedersen, ...
Innate immunity 19 (3), 290-297, 2013
242013
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
K Brekke, A Lind, C Holm-Hansen, IL Haugen, B Sørensen, M Sommerfelt, ...
PloS one 9 (11), e112556, 2014
232014
Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
AMB Kran, TØ Jonassen, M Sannes, K Jakobsen, A Lind, A Mæland, ...
Journal of clinical microbiology 47 (7), 2170-2174, 2009
232009
Why has bronchial resection and anastomosis been reported infrequently for treatment of bronchial adenoma?
AD Boyd, FC Spencer, A Lind
The Journal of thoracic and cardiovascular surgery 59 (3), 359-365, 1970
211970
Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement
H Hoel, L Heggelund, DH Reikvam, B Stiksrud, T Ueland, AE Michelsen, ...
Journal of internal medicine, 2020
182020
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4+ and CD8+ T cell responses lasting more than seven years
A Lind, M Sommerfelt, JO Holmberg, I Baksaas, B Sørensen, D Kvale
Scandinavian journal of infectious diseases 44 (8), 566-572, 2012
162012
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
A Lind, K Brekke, M Sommerfelt, JO Holmberg, HCD Aass, I Baksaas, ...
Vaccine 31 (41), 4611-4618, 2013
152013
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
MJ Jørgensen, JC Holter, EE Christensen, C Schjalm, K Tonby, ...
Scientific reports 10 (1), 1-11, 2020
112020
A parameter for IL-10 and TGF-ss mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
A Lind, K Brekke, FO Pettersen, TE Mollnes, M Trøseid, D Kvale
PLoS One 9 (1), e85604, 2014
112014
Elevated plasma sTIM-3 levels in patients with severe COVID-19
T Ueland, L Heggelund, A Lind, AR Holten, K Tonby, AE Michelsen, ...
Journal of Allergy and Clinical Immunology 147 (1), 92-98, 2021
102021
Particularism in question: an interview with Jonathan Dancy
J Dancy, A Lind, J Brannmark
102008
High MIP-1β levels in plasma predict long-term immunological nonresponse to suppressive antiretroviral therapy in HIV infection
C Prebensen, T Ueland, AE Michelsen, A Lind, FO Pettersen, TE Mollnes, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (4), 395-402, 2015
82015
The system can't perform the operation now. Try again later.
Articles 1–20